SEP 03, 2020 7:30 AM PDT

A Low-Cost COVID-19 Treatment, Made in Horses

WRITTEN BY: Tara Fernandez

Researchers in Costa Rica are turning to horses as an unlikely source of potential therapeutic antibodies against COVID-19. If these equine immunoglobulins prove to be effective in humans, they could fill a desperately needed gap in accessible pharmaceuticals to help patients with severe, life-threatening cases of COVID-19. Critically, horse antibodies would be significantly cheaper to mass-produce than human antibodies.

So far, preliminary studies in the lab show that the horse antibodies against SARS-CoV-2 were able to kill the virus. The Clodomiro Picado Institute first started using horses to create antibodies as antidotes to venomous snake and spider bites. Horses are exposed to minute amounts of these venoms and over time, build up resistance to them by generating venom-targeting antibodies. Equine antivenoms manufactured at the institute save the lives of over 500 people in Costa Rica annually, and thousands more in other countries.

The team is now channeling their expertise in equine immunology into generating COVID-19 treatments, by swapping venom injections for the spike protein of SARS-CoV-2. This work has been spurred by previous successes in generating antibodies against other pathogenic viruses such as influenza and a related coronavirus that causes the Middle East Respiratory Syndrome, or MERS.

Alape Girón, lead researcher of the COVID-19 project said, “The idea behind the antibody therapy for patients with COVID-19 is similar to that of treating patients suffering from snakebite poisoning.”

“We want to generate specific antibodies against viral structures in horses, purify the antibodies and give them to patients who are starting to fight the infection but whose immune system still does not produce enough antibodies to clear the viral particles, ” he explained.

The next steps for the team include an accelerated clinical trial to test their efficacy in 26 COVID patients, scheduled to commence shortly. Should the results turn out to be promising, more comprehensive clinical studies involving larger cohorts will be conducted. A single vial of horse antibodies, which target multiple sites on the coronavirus, will cost an estimated $100 to manufacture, around ten-fold cheaper than what it costs to make a human monoclonal equivalent.

 

 

Source: Scientific American.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 07, 2020
Coronavirus
No Evidence Showing Asthma Increases Severity of COVID-19
JUL 07, 2020
No Evidence Showing Asthma Increases Severity of COVID-19
Scientists have been scrambling to learn as much as possible about the novel coronavirus, which causes the disease COVID ...
JUL 08, 2020
Immunology
Scientists Use Genetics to Control Regulatory T Cells
JUL 08, 2020
Scientists Use Genetics to Control Regulatory T Cells
The ability to control regulatory T cells of the immune system has long been sought out by scientists, especially those ...
AUG 12, 2020
Immunology
Is Gluten Becoming More Immunoreactive?
AUG 12, 2020
Is Gluten Becoming More Immunoreactive?
In recent years, the number of people diagnosed with celiac disease has increased drastically, even with many undiagnose ...
AUG 27, 2020
Health & Medicine
Africa Eradicates Wild Poliovirus
AUG 27, 2020
Africa Eradicates Wild Poliovirus
On August 25th, Africa was officially certified free of wild poliovirus, a tremendous milestone that was decades in the ...
SEP 11, 2020
Immunology
Could a Drug for Cats Treat COVID?
SEP 11, 2020
Could a Drug for Cats Treat COVID?
Canadian researchers have discovered that a drug used to treat coronavirus infections in cats shows promise in helping C ...
OCT 08, 2020
Immunology
Immuno Metabolic Complexity and Modulating Metabolites
OCT 08, 2020
Immuno Metabolic Complexity and Modulating Metabolites
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...
Loading Comments...